Chronic venous insufficiency affects 10% to 35% of adults

Chronic venous insufficiency affects 10% to 35% of adults

ONLINE -- November 19, 2026 -- Chronic venous insufficiency (CVI) cannot be reversed, because the valve damage behind it is permanent. A patient guide from Tactile Medical, a maker of prescription compression devices, says the condition can still be slowed.

The guide cites an estimate that CVI affects approximately 10% to 35% of adults. That works out to 10 to 35 people in every 100. Prevalence rises with age and the condition becomes more common after 50. Women are affected more often than men, particularly after pregnancy or during hormonal changes.

Doctors use ultrasound and a seven-stage scale to diagnose and grade CVI.

Diagnosis starts with a symptom history and a leg examination for varicose veins, swelling, skin discoloration and open wounds. The guide calls ultrasound the most important diagnostic tool. The scan is painless and measures the direction and speed of blood flow in the leg veins. Providers use the seven stages to choose treatment and track progression.

Symptoms develop gradually and can be mistaken for other causes. According to the guide, CVI is not life-threatening, and people with a diagnosis can expect normal life expectancy with proper management. Without treatment, symptoms typically worsen over time. Care combines compression therapy, lifestyle changes and medical treatments when needed.

Tactile Medical's Flexitouch Plus and Nimbl are pneumatic compression devices that need a doctor's prescription, so a diagnosis comes first. The company says they can improve symptom management as part of a broader treatment plan. The guide gives no prices or insurance coverage details for either device.

Published by:
newsonline24_team
Products
Company